Wendy Cameron
Director/Board Member bij Beijing Tong Ren Tang Ming Qi Group LLC
Profiel
Wendy Cameron is currently the Director & Co-Owner at Beijing Tong Ren.
Tang Ming Qi Group LLC since 2009.
She previously held positions as Chairman at Washington Hospital Healthcare System, Director at Mylan Laboratories, Inc. from 2002 to 2007, Director at Mylan, Inc. from 2002 to 2011, and Independent Non-Executive Director at Mylan NV from 2002 to 2018.
She also served as a Director at Washington Health System Foundation.
Ms. Cameron's early career includes being the VP-Divisional Sales & Governmental Affairs at Cameron Coca Cola Bottling Co. from 1981 to 1998.
She obtained her undergraduate degree from Otterbein College in 1981.
Actieve functies van Wendy Cameron
Bedrijven | Functie | Begin |
---|---|---|
Beijing Tong Ren Tang Ming Qi Group LLC | Director/Board Member | 01-01-2003 |
Eerdere bekende functies van Wendy Cameron
Bedrijven | Functie | Einde |
---|---|---|
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Director/Board Member | 29-06-2018 |
Mylan Laboratories, Inc.
Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Mylan Laboratories, Inc. is engaged in developing, licensing, manufacturing, marketing and distributing generic and brand pharmaceutical products. The company manufactures and markets over 140 generic products in approximately 360 product strengths covering over 40 therapeutic categories. The company manufactures products for conditions ranging from angina to arthritis, depression to diabetes, pain to Parkinson's disease and schizophrenia to sleep disorders. The company operates through its three subsidiaries: a) Mylan Pharmaceuticals (Morgantown, West Virginia) is primarily focused on solid oral dose generic pharmaceutical products. b) Mylan Technologies (St. Albans, Vermont) is the pioneer in generic transdermal drug delivery technology and is the producer of generic transdermal patches for the U.S. market. c) UDL Laboratories (Rockford, Illinois) is the number one supplier of unit dose pharmaceuticals to hospitals and other institutions across the United States. The company was incorporated in 1970 and is headquartered in Canonsburg, PA. | Director/Board Member | 02-10-2007 |
Cameron Coca Cola Bottling Co.
Cameron Coca Cola Bottling Co. Beverages: Non-AlcoholicConsumer Non-Durables Part of The Coca-Cola Co., Cameron Coca Cola Bottling Co. bottles Coca-Cola soft drink products. Cameron Coca Cola Bottling was acquired by Coca-Cola Enterprises, Inc. /Old/ on October 21, 1998. | General Counsel | 01-01-1998 |
Washington Hospital Healthcare System
Washington Hospital Healthcare System Hospital/Nursing ManagementHealth Services The American company was founded in 1985. The CEO is Kimberly Hartz. | Chairman | - |
Washington Health System Foundation | Director/Board Member | - |
Opleiding van Wendy Cameron
Otterbein College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 7 |
---|---|
Mylan Laboratories, Inc.
Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Mylan Laboratories, Inc. is engaged in developing, licensing, manufacturing, marketing and distributing generic and brand pharmaceutical products. The company manufactures and markets over 140 generic products in approximately 360 product strengths covering over 40 therapeutic categories. The company manufactures products for conditions ranging from angina to arthritis, depression to diabetes, pain to Parkinson's disease and schizophrenia to sleep disorders. The company operates through its three subsidiaries: a) Mylan Pharmaceuticals (Morgantown, West Virginia) is primarily focused on solid oral dose generic pharmaceutical products. b) Mylan Technologies (St. Albans, Vermont) is the pioneer in generic transdermal drug delivery technology and is the producer of generic transdermal patches for the U.S. market. c) UDL Laboratories (Rockford, Illinois) is the number one supplier of unit dose pharmaceuticals to hospitals and other institutions across the United States. The company was incorporated in 1970 and is headquartered in Canonsburg, PA. | Health Technology |
Mylan, Inc.
Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Health Technology |
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Health Technology |
Cameron Coca Cola Bottling Co.
Cameron Coca Cola Bottling Co. Beverages: Non-AlcoholicConsumer Non-Durables Part of The Coca-Cola Co., Cameron Coca Cola Bottling Co. bottles Coca-Cola soft drink products. Cameron Coca Cola Bottling was acquired by Coca-Cola Enterprises, Inc. /Old/ on October 21, 1998. | Consumer Non-Durables |
Beijing Tong Ren Tang Ming Qi Group LLC | |
Washington Hospital Healthcare System
Washington Hospital Healthcare System Hospital/Nursing ManagementHealth Services The American company was founded in 1985. The CEO is Kimberly Hartz. | Health Services |
Washington Health System Foundation | Miscellaneous |